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We performed a meta-analysis to compare the impact of extracorporeal cardiopulmonary resuscitation 
(ECPR) to that of conventional cardiopulmonary resuscitation (CCPR) in adult patients who experience 
cardiac arrest of cardiac origin. A literature search was performed using criteria set forth in a predefined 
protocol. Report inclusion criteria were that ECPR was compared to CCPR in adult patients with cardiac 
arrest of cardiac origin, and that survival and neurological outcome data were available. Exclusion 
criteria were reports describing non-cardiac origin arrest, review articles, editorials, and nonhuman 
studies. The efficacies of ECPR and CCPR were compared in terms of survival and neurological outcome. 
A total of 38,160 patients from 7 studies were ultimately included. ECPR showed similar survival (odds 
ratio [OR] 2.26, 95% confidence interval [CI] 0.45–11.20) and neurologic outcomes (OR 3.14, 95% CI 
0.66–14.85) to CCPR in out-of-hospital cardiac arrest patients. For in-hospital cardiac arrest (IHCA) 
patients, however, ECPR was associated with significantly better survival (OR 2.40, 95% CI 1.44–3.98) 
and neurologic outcomes (OR 2.63, 95% CI 1.38–5.02) than CCPR. Hence, ECPR may be more effective 
than CCPR as an adjuvant therapy for survival and neurologic outcome in cardiac-origin IHCA patients.
Cardiopulmonary resuscitation (CPR) is performed in adult cardiac arrest patients to elicit subsequent return of 
spontaneous circulation (ROSC) and recovery of cardiovascular and neurologic function1,2. Recent trends show 
that the survival rates of adult cardiac arrest patients are rising, and that these improvements are accompanied by 
more favourable neurological outcomes3. However, such advances remain far from satisfactory.
To increase the survival rate post-CPR, the application of extracorporeal membrane oxygenation (ECMO) 
during CPR, referred to as extracorporeal CPR (ECPR), has been selectively attempted on adult patients who 
experience cardiac arrest due to reversible aetiologies4–7. Recently, several successful ECPR cases have been 
reported in in-hospital cardiac arrest (IHCA) events, or have been witnessed in out-of-hospital cardiac arrest 
(OHCA) patients4,8–17.
ECPR is currently used as an adjuvant therapy of conventional cardiopulmonary resuscitation (CCPR). ECPR 
is not only a highly invasive technique but also requires an expert team approach18; nevertheless, it might be a 
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suitable alternative for adult cardiac arrest patients in whom CCPR does not produce stable ROSC or is refractory 
to CPR.
This study aimed to evaluate the efficacy of ECPR compared to CCPR as an adjuvant therapy in adult 
cardiac-origin arrest patients. Hence, we performed a meta-analysis to examine survival rates and neurologic 
outcomes in ECPR and CCPR patients.
Results
Study and patient characteristics. Our literature search revealed 7 eligible studies; 38,160 patients were 
included in the meta-analysis (Fig. 1). The main attributes of these studies are shown in Table 1. All included 
studies were observational. Three studies described prospective patient cohorts and the remaining 4 described 
retrospective cohorts. Propensity score matching analysis was used in 5 studies. Overall, survival and neurologic 
outcomes were obtained from 7 and 6 articles, respectively. One study measured adjusted odds ratios (ORs) 
with 95% confidence intervals (CIs) using multivariate analysis, while 6 only compared the frequency of patients 
between survivors (good neurologic outcome) and non-survivors (poor neurologic outcome). In only 1 study 
were propensity score matching and multivariate ORs all used to adjust for covariates.
Quality of the included studies. Among the 7 included studies, 3 fulfilled all of the quality criteria4,11,16 
while 2 studies were assessed as high-risk owing to confounding variables12,14. When we were not able to assess 
quality because of the lack of a clear description of the contents of each risk of bias (ROB) domain, we described 
the quality as ‘unclear’. Five studies (2 on OHCA and 3 on IHCA) that used propensity score matching achieved 
> 9 points in quality assessment and were therefore deemed high quality4,9,11,16,17. The other 2 studies were consid-
ered low quality12,14 (see Supplementary Figs S1 and S2).
Clinical endpoints. Survival in ECPR vs. CCPR recipients. Although the overall survival rate was higher in 
ECPR than CCPR (OR 2.29, 95% CI 1.07–4.87), ECPR showed significantly better survival compared to CCPR 
only in IHCA patients (OR 2.40, 95% CI 1.44–3.98; I2 = 0%). However, the survival rate in ECPR recipients was 
similar to that of CCPR recipients among OHCA patients (OR 2.26, 95% CI 0.45–11.20; I2 = 93%) (Fig. 2).
Neurologic outcome in ECPR vs. CCPR recipients. Our accumulated data suggested that the overall neurologic 
outcome in ECPR patients was better than in CCPR patients (OR 2.82, 95% CI 1.36–5.82). ECPR showed similar 
Figure 1. Flow chart of the study selection process for this meta-analysis. 
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Study
Recruitment 
period and 
country
Study type and 
place of cardiac 
arrest
Propensity 
score 
matching 
used OR
Number of participants 
(ECPR/CCPR)
Age, mean (year)a Outcome
ECPR CCPR Survival
Neurologic 
outcome 
(good/poor)
Chen4 2004–2006 Taiwan
Prospective 
Single centre 
IHCA
Yes Univariate 172 (59/113) 57.4 ± 12.5 60.3 ± 13.3 discharge CPC (12/345) discharge
Lin8 b 2004–2006 Taiwan
Prospective 
Single centre 
IHCA
Yes Univariate 118 (55/63) 59.0 ± 11.7 60.6 ± 12.7 28 days CPC (12/345) discharge
Shin9 2003–2009 South Korea
Retrospective 
Single centre 
IHCA
Yes Univariate 406 (85/321) 59.9 ± 15.3 61.6 ± 14.2 in hospital GOS (1/2345) discharge
Shin10 b 2003–2009 South Korea
Retrospective 
Single centre 
IHCA
Yes Univariate 406 (85/321) 59.9 ± 15.3 61.6 ± 14.2 28 days GOS (1/2345) 2 year
Maekawa11 2000–2004  Japan
Prospective 
Single centre 
OHCA
Yes Univariate 162 (53/109 54 (47–60) 71 (59–80) discharge CPC (12/345) 90 days
Sakamoto12 2008–2012  Japan
Prospective 
Multi-centre 
OHCA
No Univariate 454 (260/194) 56.3 ± N/A 58.1 ± N/A 28 days CPC (12/345) 28 days
Kim13 c 2006–2013 Korea
Prospective 
Single centre 
OHCA
Yes Univariate 499 (55/444) 53 (41–68) 69 (56–77) discharge CPC (12/345) discharge
Chou14 2006–2010 Taiwan
Retrospective 
IHCA Single 
centre
No Univariate 66 (43/23) 60.5 ± 11.6 69.6 ± 13.3 discharge —
Siao15 d 2011–2013 Taiwan
Retrospective 
Single centre 
IHCA
No Multivariate 60 (20/40) 54.5 ± 11.9 60.2 ± 11.2 discharge CPC (12/34) discharge
Blumenstein17 2009–2013 Germany
Retrospective 
Single centre 
IHCA
Yes Univariate 353 (52/272) 72 (55–77.9) 75.29 (67.4–79.1) 30 days
CPC (12/345) 
30 days
Choi16 2009–2013 South Korea
Retrospective 
Multi-centre 
OHCA
Yes Multivariate 36,547 (320/36,227) 56 (45–68) 67 (54–77) discharge CPC (12/345) discharge
Table 1.  Details of included studies. Abbreviations: OR, odds ratio; ECPR, extracorporeal cardiopulmonary 
resuscitation; CCPR, conventional cardiopulmonary resuscitation; IHCA, in-hospital cardiac arrest; OHCA, 
out-of-hospital cardiac arrest; CPC, Cerebral Performance Category Scale; GOS, Glasgow Outcome Scale; N/A, 
not available. aAge was presented as median (interquartile range) or mean ± standard deviation. bNot included 
in the meta-analysis because of duplicated data sources. cNot included in the meta-analysis because the patient 
data was previously published in the Choi et al.16 trial. dNot included in the meta-analysis because the patient 
data was not reported separately for OHCA and IHCA patients.
Figure 2. Survival to discharge from hospital or to 28 days post-cardiac arrest. CI: confidence interval, SE: 
standard error.
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neurologic outcome to CCPR in OHCA patients (OR 3.14, 95% CI 0.66–14.85; I2 = 80%), while ECPR was associ-
ated with better neurologic outcome than CCPR in IHCA patients (OR 2.63, 95% CI 1.38–5.02; I2 = 3%) (Fig. 3).
Subgroup analysis and sources of heterogeneity. We performed subgroup analysis according to the study type 
(prospective vs. retrospective), the assessment of quality, and the use of propensity score matching analysis in 
OHCA and IHCA patients.
Additionally, we analysed subgroups according to the presumed aetiology of arrest, initial electrocardio-
graphic rhythm, and whether the arrest was witnessed.
Subgroup analysis in OHCA patients. ECPR was associated with better survival than CCPR when evaluated 
according to study type (OR 4.89, 95% CI 2.75–8.70; I2 = 0%). When assessing for quality, the survival owing 
to ECPR was similar to that owing to CCPR (OR 1.43, 95% CI 0.23–9.00), and heterogeneity was still high 
(I2 = 83%).
The neurologic outcome in ECPR recipients was better than in CCPR recipients when analysed according to 
study type (OR 7.12, 95% CI 2.68–18.95; I2 = 0%). However, ECPR patients showed similar neurologic outcomes 
to CCPR patients when assessing for quality (OR 1.72, 95% CI 0.38–7.71; I2 = 63%) (Table 2).
Subgroup analysis in IHCA patients. ECPR was associated with better survival than CCPR when analysed 
according to study type (OR 2.44, 95% CI 1.35–4.41; I2 = 0%). When assessing for quality, ECPR was significantly 
associated with better survival than CCPR (OR 2.52, 95% CI 1.44–4.43) with low heterogeneity (I2 = 0%).
The neurologic outcome in ECPR recipients was also better than in CCPR recipients when analysed for study 
type (OR 2.95, 95% CI 0.19–9.59; I2 = 51%) and for assessment of quality (OR 2.63, 95% CI 1.38–5.02; I2 = 3%) 
(Table 2).
Subgroup analysis according to additional factors. ECPR showed similar survival to CCPR with high hetero-
geneity when analysing patients with arrests of presumed cardiac origin (OR 1.62, 95% CI 0.64–4.09; I2 = 73%). 
In patients where the aetiologies of cardiac arrest were not stated, ECPR was associated with better survival than 
CCPR (OR 3.54, 95% CI 1.89–6.64; I2 = 40%). Only 1 study specifically described initial ventricular fibrillation or 
pulseless ventricular tachycardia in terms of initial electrocardiographic rhythm; in the remaining 6 studies, the 
survival rates owing to ECPR and CCPR were similar (OR 1.92, 95% CI 0.92–3.98; I2 = 73%).
ECPR was associated with better neurologic outcome than CCPR patients in reports not mentioning the 
aetiologies of arrest (OR 4.27, 95% CI 1.53–11.89; I2 = 56%) or the nature of the initial electrocardiogram rhythm 
(OR 2.15, 95% CI 1.12–4.14; I2 = 42%).
All studies that limited their analyses to witnessed arrests were in IHCA patients; in this group, ECPR was 
associated with better survival and neurologic outcomes than CCPR, with low heterogeneity (survival OR 2.40, 
95% CI 1.44–3.98; I2 = 0%; neurologic outcome OR 2.63, 95% CI 1.38–5.02; I2 = 3%) (Table 3).
Discussion
In this meta-analysis, we found that ECPR was associated with improved survival and neurologic outcome com-
pared to CCPR in adult cardiac-origin IHCA patients. In contrast, ECPR showed survival and neurologic out-
comes that were similar to CCPR in OHCA patients.
We excluded four studies after full-text review8,10,13,14. The reasons were as follows: First, Lin et al.8 and Shin 
et al.10 were excluded because their data sources were reproduced from Chen et al.4 and Shin et al.9 respectively. 
Second, Choi et al.16 and Kim et al.13 appear to have reported data from the same patients, as the same national 
Figure 3. Good neurologic outcome (Cerebral Performance Category 1–2 or Glasgow Outcome Scale 1) to 
discharge from hospital, or for 28 or 90 days post-cardiac arrest. CI: confidence interval, SE: standard error.
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South Korean database that held all data from OHCAs managed by the national Emergency Medical Services 
system had been used in both studies. Therefore, the study by Kim et al.13 that was performed at a single tertiary 
hospital was excluded. Third, the study by Siao et al.15 was also not included in the meta-analysis because OHCA 
and IHCA patient outcomes (such as survival or neurologic outcomes) were not reported separately.
This study excluded patients older than 75 years because aging is itself a significant variable in decreased 
survival13. Nevertheless, it is highly likely that aging is still a potent confounder for survival in our study because 
elderly patients under 75 years were included. Our analysis showed that the mean age of CCPR patients was 
higher than that of the ECPR group. Thus, unless propensity score matching was performed, the confounding 
effect of age could have resulted in the underestimation of survival and neurologic outcome in the CCPR group. 
The more elderly patients were included, the lower the survival rate achieved. In the meta-analysis of observa-
tional studies using score matching, the survival and neurologic outcomes of the ECPR group were significantly 
higher than that of the CCPR group only in IHCA patients (Table 2).
Because there are few randomized controlled trials in the field of resuscitation, several confounding fac-
tors should be controlled using multivariate analysis for the included observational studies. When perform-
ing our meta-analysis, we prioritized the adjusted ORs produced by multivariate analysis after score matching. 
Unfortunately, certain articles provided only univariate ORs after score matching; hence, the score for confound-
ing factors was necessarily low upon evaluation for ROB. It should be noted that the score matching method 
cannot completely eliminate selection bias in the included studies. Moreover, survival to discharge data is subject 
to significant influence by actions such as withdrawing life-sustaining therapy, prolonging life support in ECPR 
candidates, or abiding by do-not-resuscitate orders.
In this study, heterogeneities in the forests plots are indicative of major confounding factors. Therefore, a 
random effect model was employed for statistical analysis because of ECPR’s inconsistent effect on outcome. 
Nevertheless, there was some selection bias in the included studies because their recruitment periods spanned 
more than a decade, during which technological changes such as the emergence of mechanical CPR devices 
occurred and CPR guidelines were updated twice (in 2005 and 2010). Some included studies also reported com-
bined outcomes, including ECPR with therapeutic hypothermia or coronary interventions, while others either 
did not combine outcomes or did not specify whether or not they did, making comparisons difficult.
In subgroup analysis for both IHCA and OHCA patients, ECPR was associated with better survival and neu-
rologic outcome than CCPR in IHCA patients. Additionally, heterogeneity was low in studies for IHCA patients, 
illustrating consistency among the results for these patients. We postulate that the association of ECPR with better 
survival rates may be due to cardiac events in IHCA patients being detected more promptly by clinicians; ECPR 
could be selectively implemented in patients deemed to have reversible cardiac arrest causes after application of 
ECMO.
In contrast, ECPR and CCPR produced almost equal survival rates and neurologic outcomes in OHCA 
patients; furthermore, heterogeneity was high among OHCA patients, revealing inconsistency among the results. 
This was likely because survival of ECPR recipients among OHCA patients was affected by prehospitalization fac-
tors such as delay before intervention and prehospital CPR quality19. Compared to IHCA patients, the resolution 
of the cardiac-based causes for OHCA patients could therefore have been delayed20.
On the other hand, post-resuscitation care for OHCA patients, including both reperfusion therapy and thera-
peutic hypothermia, should be considered in the evaluation of the effectiveness of ECPR. One study reported that 
there was no significant survival benefit in ECPR compared to CCPR after score matching for post-resuscitation 
Characteristics
Survival Neurologic outcomes
N OR (95% CI)
p value for 
heterogeneity I2, % N OR (95% CI)
p value for 
heterogeneity I2, %
OHCA
All 3 2.26 (0.45–11.20) < 0.00001 93 3 3.14 (0.66–14.85) 0.007 80
Study type
 ROS 1 0.63 (0.39–1.03) N/A 1 0.94 (0.41–2.14) N/A
 POS 2 4.89 (2.75–8.70) < 0.00001 0 2 7.12 (2.68–18.95) 0.52 0
Assessment of quality
 High* 2 1.43 (0.23–9.00) 0.02 83 2 1.72 (0.38–7.71) 0.10 63
 Low 1 5.03 (2.69–9.41) N/A 1 8.94 (2.69–29.64) N/A
IHCA
All 4 2.40 (1.44–3.98) 0.63 0 3 2.63 (1.38–5.02) 0.36 3
Study type
 ROS 3 2.44 (1.35–4.41) 0.43 0 2 2.95 (0.19–9.59) 0.16 51
 POS 1 2.30 (0.86–6.13) N/A 1 2.44 (0.88–6.76) N/A
Assessment of quality
 High* 3 2.52 (1.44–4.43) 0.46 0 3 2.63 (1.38–5.02) 0.36 3
 Low 1 1.93 (0.60–6.23) N/A — — — —
Table 2.  Subgroup analysis according to the type of arrest (OHCA vs. IHCA). Abbreviations: N, the number 
of studies; OR, odds ratio; 95% CI, 95% confident interval; OHCA, out-of-hospital cardiac arrest; IHCA, in-
hospital cardiac arrest; ROS, retrospective observational study; POS, prospective observational study; N/A, not 
available. *High-quality studies were those that achieved > 9 points in quality assessment. The propensity score 
matching method was used in all high-quality studies.
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care16. This suggests that post-resuscitation care could be the most important factor in survival and neurologic 
outcomes regardless of ECMO use during CPR.
In a recent systematic review21, the benefit of ECPR was undetectable when compared to CCPR. Nevertheless, 
our analysis incorporated an additional, critical meta-analysis that included 36,180 patients16; as a result, we 
showed that ECPR was significantly more beneficial than CCPR in cardiac origin IHCA patients.
There were several limitations in this study. First, complications due to ECPR that could affect the survival 
and neurologic outcome of patients were not reported in the included studies. In particular, bleeding after ECPR 
is considered an important complication22–26. In the 2014 ELSO registry, incidences of significant bleeding of 
an internal organ such as the central nervous system (2.2%) or gastrointestinal tract (4.0%) were reported after 
ECPR, in addition to minor bleeding in the cannular (19.8%) or surgical sites (23%). Moreover, life-threatening 
complications of ECPR such as cardiac tamponade (5.4%) and disseminated intravascular coagulation (4.1%) 
were reported26.
Second, scoring for the severity of the cause of arrest was not reported in the included studies. Successful 
rescue angioplasty guarantees the survival of patients after ROSC27–29. In contrast, the patients do not have a high 
chance of survival after failed rescue angioplasty, even after undergoing ECPR. The failure of coronary angioplasty 
correlates with the increase in both the number of obstructed coronary vessels and the severity of each coronary 
artery obstruction. In patients with triple vessel disease, heart surgery may be required30,31. Similarly, the severity 
score is closely associated with survival and neurologic outcome.
Third, generalizability is not ensured in this study because the included patients were geographically confined 
to East Asia (Taiwan, Japan and South Korea)4,9,11–13,16. Therefore, our results may have been different if cohorts 
from other countries or races were included. Only 2 of the included studies were multicentre investigations12,16, 
while the remainder were all single-centre investigations4,9,11,13. Along with race, the low number of multicentre 
studies also contributed to decreased representation. To yield more robust conclusions, additional studies that 
have wide representation are required.
Fourth, logistics and human resources that are strongly correlated with the survival rate of CPR are not 
reported in the included studies. Time for ambulance arrival and time to first shock by automated external defi-
brillators are well-known CPR-related parameters. However, there are few studies reporting such logistics in our 
systematic review11,16. Factors such as the willingness of the lay public to perform CPR and training of hospital 
teams are also not evident in our included studies.
In conclusion, data suggest that ECPR is more effective than CCPR as an adjuvant therapy for survival and 
neurologic outcome in cardiac-origin IHCA patients. However, no such benefits were observed for ECPR in 
OHCA patients.
Methods
Our study was based on the principles outlined by the Meta-analysis of Observational Studies in Epidemiology 
(MOOSE)32 and the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) groups33. 
Briefly, we devised a question based on population, intervention, comparison, and outcome (PICO). To that end, 
literature searches and critical assessments were performed. We summarized the eligible studies, and their out-
comes were evaluated in a meta-analysis. The PICO question was as follows: “In adult patients of cardiac-origin 
arrest (P), does cardiopulmonary resuscitation with ECMO (I), compared to conventional cardiopulmonary 
resuscitation (C), improve survival rate and neurological outcome (O)?”
Search strategy. A literature search was performed by 2 experienced reviewers (C. Ahn and W. Kim) on 
22 December 2015. The search encompassed the MEDLINE and EMBASE databases via the Ovid interface, as 
well as the Cochrane library. Search terms included “cardiopulmonary resuscitation” or “resuscitation” or “heart 
massage” or “out-of-hospital cardiac arrest” or “cardiac arrest” or “cardiac massage” or “CPR” and “extracorporeal 
circulation” or “extracorporeal membrane oxygenation” or “extracorporeal oxygenation” or “ECMO” or “E-CPR” 
Characteristics
Survival Neurologic outcomes
N OR (95% CI)
p value for 
heterogeneity I2, % N OR (95% CI)
p value for 
heterogeneity I2, %
All 7 2.29 (1.07–4.87) < 0.0001 81 6 2.82 (1.36–5.82) 0.03 59
Presumed aetiology
 Cardiac-origin 4 1.62 (0.64–4.09) 0.01 73 3 1.81 (0.75–4.32) 0.16 46
 Not stated 3 3.54 (1.89–6.64) 0.19 40 3 4.27 (1.53–11.89) 0.10 56
Initial ECG rhythm
 VF/pulseless VT 1 5.03 (2.69–9.41) N/A 1 8.94 (2.69–29.64) N/A
 Not stated 6 1.92 (0.92–3.98) 0.003 73 5 2.15 (1.12–4.14) 0.14 42
Witnessed arrest
 Witnessed* 4 2.40 (1.44–3.98) 0.63 0 3 2.63 (1.38–5.02) 0.36 3
 Not stated 3 2.26 (0.45–11.20) < 0.00001 93 3 3.14 (0.66–14.85) 0.007 80
Table 3.  Subgroup analysis of studies according to presumed aetiology, initial ECG rhythm, and whether 
the arrest was witnessed. Abbreviations: N, the number of studies; OR, odds ratio; 95% CI, 95% confident 
interval; ECG, electrocardiogram; VF, ventricular fibrillation; VT, ventricular tachycardia; N/A, not available.
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or “ECPR” or “ECLS” or “extracorporeal life support”. We included articles that reported any prospective or ret-
rospective cohort studies that addressed our PICO question.
Study selection. All identified studies were inputted into the reference management software Endnote 7.4. 
The 2 reviewers checked the title, abstract, or type of each of the identified articles. We did not consider articles 
that fell under the following exclusion criteria: reviews, case reports, editorials, letters, comments, conference 
abstracts, or meta-analyses; animal studies; languages other than English; duplicate studies; irrelevant popula-
tions; and inappropriate controls. In case of disagreement between the 2 reviewers, a third reviewer (KS Choi) 
intervened, and differences were discussed until consensus was reached. After eliminating the excluded abstracts, 
we acquired the full-texts of the chosen articles, which were then rescreened and evaluated more thoroughly for 
eligibility using the same exclusion criteria. Ultimately, our selected studies included adult patients (age 18–75 
years) who received CCPR or ECPR after cardiac arrest due to cardiac origin.
Risk of bias in individual studies. The Risk of Bias Assessment Tool for Nonrandomized Studies was used 
to assess ROB in our included studies34. ROB assessment was performed across 6 domains: selection of partici-
pants, confounding variables, measurement of exposure, blinding of outcome assessment, incomplete outcome 
data, and selective reporting. If there was disagreement of opinion in the ROB assessment, the majority decision 
was accepted. We used the following 3 quality criteria to assess ROB from the standpoint of confounding varia-
bles: the use of multivariate ORs, observational studies that are prospective in nature, and the use of propensity 
score matching. If at least 2 out of 3 criteria were fulfilled, the ROB was assessed as low risk. Otherwise, the ROB 
was assessed as high risk.
The methodological scores of identified studies were assigned values of 2, 1, and 0 for low, unclear, and 
high-risk studies, respectively. Studies achieving more than 9 points after totalling each 6-domain score were 
considered to be high quality.
Outcome measures. The outcome was defined as survival and neurological outcome at hospital dis-
charge or thereafter. The neurological outcome scores were dichotomized as good or poor based on the Glasgow 
Outcome Scale (1: good outcome; 2–5: poor outcome) and Cerebral Performance Category Scale (1–2: good 
outcome; 3–5: poor outcome).
Statistical analysis. We combined studies using the Review Manager software version 5.3 (RevMan; The 
Cochrane Collaboration 2012, The Nordic Cochrane Centre, Copenhagen, Denmark). Because the effect of ECPR 
in comparison with CCPR on survival or neurologic outcome was inconsistent, we used a random-effects model. 
We employed the generic inverse variance method in RevMan to estimate the average treatment effect (using OR) 
for each outcome, and measured the 95% CI. We also calculated 95% prediction intervals to estimate the range of 
plausible treatment effects. The heterogeneity in each analysis was quantified by tau-squared and I-squared statis-
tics. We assessed the effect of ECPR treatment compared to CCPR, and performed a subgroup analysis based on 
the location of cardiac arrest (OHCA/IHCA), study type, and the use of propensity score matching.
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